Paul Polakis

Genesys (United States) — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

71h-index28.5kcitations244works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Wnt/β-catenin signaling in development and cancer(63), Monoclonal and Polyclonal Antibodies Research(62), HER2/EGFR in Cancer Research(55), Cancer-related gene regulation(43), Melanoma and MAPK Pathways(29)

Publications244 total

Supplementary Figure 5 from MAPK Pathway Inhibition Enhances the Efficacy of an Anti-Endothelin B Receptor Drug Conjugate by Inducing Target Expression in Melanoma
2023Open Access
Data from An Anti-GDNF Family Receptor Alpha 1 (GFRA1) Antibody–Drug Conjugate for the Treatment of Hormone Receptor–Positive Breast Cancer
2023Open Access
Supplementary Figure 6 from MAPK Pathway Inhibition Enhances the Efficacy of an Anti-Endothelin B Receptor Drug Conjugate by Inducing Target Expression in Melanoma
2023Open Access
Figures S1-S4, Tables S1-S2 from An Anti-GDNF Family Receptor Alpha 1 (GFRA1) Antibody–Drug Conjugate for the Treatment of Hormone Receptor–Positive Breast Cancer
2023Open Access
Supplementary Figure 1 from MAPK Pathway Inhibition Enhances the Efficacy of an Anti-Endothelin B Receptor Drug Conjugate by Inducing Target Expression in Melanoma
2023Open Access
Supplementary Figure 3 from MAPK Pathway Inhibition Enhances the Efficacy of an Anti-Endothelin B Receptor Drug Conjugate by Inducing Target Expression in Melanoma
2023Open Access
Supplementary Figure 1 from MAPK Pathway Inhibition Enhances the Efficacy of an Anti-Endothelin B Receptor Drug Conjugate by Inducing Target Expression in Melanoma
2023Open Access
Supplementary Figure 6 from MAPK Pathway Inhibition Enhances the Efficacy of an Anti-Endothelin B Receptor Drug Conjugate by Inducing Target Expression in Melanoma
2023Open Access
Supplementary Figure 2 from MAPK Pathway Inhibition Enhances the Efficacy of an Anti-Endothelin B Receptor Drug Conjugate by Inducing Target Expression in Melanoma
2023Open Access
Supplementary Figure 3 from MAPK Pathway Inhibition Enhances the Efficacy of an Anti-Endothelin B Receptor Drug Conjugate by Inducing Target Expression in Melanoma
2023Open Access
Supplementary Table 3 from MAPK Pathway Inhibition Enhances the Efficacy of an Anti-Endothelin B Receptor Drug Conjugate by Inducing Target Expression in Melanoma
2023Open Access
Supplementary Table 2 from MAPK Pathway Inhibition Enhances the Efficacy of an Anti-Endothelin B Receptor Drug Conjugate by Inducing Target Expression in Melanoma
2023Open Access
Supplementary Table 1 from MAPK Pathway Inhibition Enhances the Efficacy of an Anti-Endothelin B Receptor Drug Conjugate by Inducing Target Expression in Melanoma
2023Open Access
Supplementary Figure 2 from MAPK Pathway Inhibition Enhances the Efficacy of an Anti-Endothelin B Receptor Drug Conjugate by Inducing Target Expression in Melanoma
2023Open Access
Supplementary Figure 4 from MAPK Pathway Inhibition Enhances the Efficacy of an Anti-Endothelin B Receptor Drug Conjugate by Inducing Target Expression in Melanoma
2023Open Access
Data from MAPK Pathway Inhibition Enhances the Efficacy of an Anti-Endothelin B Receptor Drug Conjugate by Inducing Target Expression in Melanoma
2023Open Access
Data from An Anti-GDNF Family Receptor Alpha 1 (GFRA1) Antibody–Drug Conjugate for the Treatment of Hormone Receptor–Positive Breast Cancer
2023Open Access
Supplementary Methods, Figure Legends from MAPK Pathway Inhibition Enhances the Efficacy of an Anti-Endothelin B Receptor Drug Conjugate by Inducing Target Expression in Melanoma
2023Open Access
Data from Modulating Therapeutic Activity and Toxicity of Pyrrolobenzodiazepine Antibody–Drug Conjugates with Self-Immolative Disulfide Linkers
2023Open Access
Supplementary Information from Modulating Therapeutic Activity and Toxicity of Pyrrolobenzodiazepine Antibody–Drug Conjugates with Self-Immolative Disulfide Linkers
2023Open Access
page 1 of 13Next →

Frequent Co-authors

Bonnee Rubinfeld(18), Iris Albert(11), S Munemitsu(9), Frank McCormick(6), Helga Raab(5), Emilio Porfiri(4), Jagath R. Junutula(4), Sunil Bhakta(4), Kelly M. Flagella(4), Susan D. Spencer(4), Brian Souza(4), Matthew J. Hart(4), Sarajane Ross(3), Richard Vandlen(3), Mark X. Sliwkowski(3), Richard H. Scheller(3), Oliver Müller(3), Marinella Callow(3), Mike Costa(3), Robin Clark(3)